(Q54469265)

30 May 2018

title

Hemodynamic effects of intravenous amiodarone. (English)

1 reference

30 May 2018

1 reference

E J Kosinski

1

1 reference

30 May 2018

J B Albin

2

1 reference

30 May 2018

E Young

3

1 reference

30 May 2018

S M Lewis

4

1 reference

30 May 2018

O S LeLand

5

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 September 1984

1 reference

30 May 2018

Journal of the American College of Cardiology

published in

1 reference

30 May 2018

volume

4

1 reference

30 May 2018

issue

3

1 reference

30 May 2018

page(s)

565-570

1 reference

30 May 2018

Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

Amiodarone in refractory life-threatening ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

Adverse reactions during treatment with amiodarone hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980103-5

7 January 2021

10.1016/S0735-1097(84)80103-5

Identifiers

DOI

1 reference

30 May 2018

PubMed ID

6470338

1 reference

30 May 2018